APA

Perez L. E., Fernandez H., Ayala E., Beato F., Neuger A., Pidala J., Schell M. J. & Anasetti C. (20180716). Visilizumab with tacrolimus and methotrexate for GvHD prevention after allogeneic hematopoietic cell transplantation from mismatched unrelated donors. : Bone marrow transplantation.

Chicago

Perez L E, Fernandez H, Ayala E, Beato F, Neuger A, Pidala J, Schell M J and Anasetti C. 20180716. Visilizumab with tacrolimus and methotrexate for GvHD prevention after allogeneic hematopoietic cell transplantation from mismatched unrelated donors. : Bone marrow transplantation.

Harvard

Perez L. E., Fernandez H., Ayala E., Beato F., Neuger A., Pidala J., Schell M. J. and Anasetti C. (20180716). Visilizumab with tacrolimus and methotrexate for GvHD prevention after allogeneic hematopoietic cell transplantation from mismatched unrelated donors. : Bone marrow transplantation.

MLA

Perez L E, Fernandez H, Ayala E, Beato F, Neuger A, Pidala J, Schell M J and Anasetti C. Visilizumab with tacrolimus and methotrexate for GvHD prevention after allogeneic hematopoietic cell transplantation from mismatched unrelated donors. : Bone marrow transplantation. 20180716.